Clinicians should review all medications, as semaglutide's effect on gastric emptying may affect the absorption of oral medications, particularly those with a narrow therapeutic index
This dual action appears to amplify appetite suppression and metabolic regulation beyond what GLP-1 activation alone produces, which is why clinical trials consistently show greater average weight loss with tirzepatide
Multiple plausible mechanisms explain why the medication can change breath odor, and those mechanisms point to practical ways you can monitor and manage the issue rather than panic about it
The other thing that sets it apart from most treatments is how it's delivered
The same connections we describe in how mental health and weight are linked, through sleep, stress, and cortisol, run in both directions here
Novo Nordisk says it is "pursuing multiple" strategies to end the practice, "including litigation." Compounding pharmacies typically help patients whose needs aren't met by existing approved drugs